PAVmed (NASDAQ: PAVM) Scott Dols reports 5.4% stake, 346,155 shares

Rhea-AI Filing Summary

PAVmed Inc. Schedule 13G filed by Scott V. Dols reports beneficial ownership of 346,155 shares of Common Stock, representing 5.4% of the class. The percent is calculated using 6,383,089 shares outstanding as of March 27, 2026 per the company annual report.

Key Figures

Beneficial ownership: 346,155 shares Percent of class: 5.4% Shares outstanding: 6,383,089 shares +1 more

4 metrics

Beneficial ownership 346,155 shares amount beneficially owned by Scott V. Dols

Percent of class 5.4% percent of Common Stock outstanding as reported

Shares outstanding 6,383,089 shares outstanding shares used to calculate percentage, as of <date>March 27, 2026</date>

Trust-held shares 230,770 shares shares held by a trust for which Mr. Dols is trustee (included in total)

Key Terms

Schedule 13G, beneficially owns, sole dispositive power

3 terms

Schedule 13G regulatory

"This is filed by Scott V. Dols ("Mr. Dols" or the "Reporting Person")."

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficially owns financial

"Mr. Dols beneficially owns 346,155 shares of Common Stock"

Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 346,155 shares"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PAVmed Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

70387R502

(CUSIP Number)

03/27/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 70387R502

1

Names of Reporting Persons

Dols Scott V.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 346,155.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 346,155.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

346,155.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PAVmed Inc.
(b)	Address of issuer's principal executive offices: 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017.
Item 2.
(a)	Name of person filing: This Schedule 13G is filed by Scott V. Dols ("Mr. Dols" or the "Reporting Person"). Any disclosures herein with respect to persons other than the Reporting Person are made on information and belief after making inquiry to the appropriate party. The filing of this Schedule 13G should not be construed in and of itself as an admission by the Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.
(b)	Address or principal business office or, if none, residence: The principal business address of the Reporting Person is 19822 Wetherby Lane, Lutz, Florida 33549.
(c)	Citizenship: The Reporting Person is a citizen of the United States.
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP Number(s): 70387R502
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Mr. Dols beneficially owns 346,155 shares of Common Stock, including 230,770 shares held by a trust of which Mr. Dols is trustee. Mr. Dols may be deemed to beneficially own the shares of Common Stock held by the trust.
(b)	Percent of class: Mr. Dols beneficially owns 5.4% of the outstanding shares of Common Stock. The percentage of beneficial ownership is calculated based on 6,383,089 shares of Common Stock outstanding as of March 27, 2026, as set forth in the Company's annual report on Form 10-K filed on March 27, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 346,155 shares
	(ii) Shared power to vote or to direct the vote: 0 shares
	(iii) Sole power to dispose or to direct the disposition of: 346,155 shares
	(iv) Shared power to dispose or to direct the disposition of: 0 shares
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dols Scott V.

Signature:	/s/ Scott V. Dols
Name/Title:	Scott V. Dols
Date:	04/08/2026

FAQ

What stake does Scott V. Dols report in PAVmed (PAVM)?

Mr. Dols reports beneficial ownership of 346,155 shares, equal to 5.4% of PAVmed common stock. The filing cites 6,383,089 shares outstanding as of March 27, 2026, per the company’s Form 10-K used to calculate the percentage.

How many PAVmed shares are used to calculate the 5.4% figure?

The percentage is based on 6,383,089 shares outstanding as of March 27, 2026. That outstanding-share count is taken from the company’s annual report on Form 10-K filed March 27, 2026, which the filing cites for its ownership calculation.

Does Scott V. Dols exercise voting and disposition control over the shares?

Yes. The filing states Mr. Dols has sole voting power and sole dispositive power over 346,155 shares. It also discloses 230,770 shares are held by a trust for which he is trustee and may be deemed beneficially owned.

Are trust-held shares included in the reported beneficial ownership for PAVmed (PAVM)?

Yes. The filing explicitly includes 230,770 shares held by a trust of which Mr. Dols is trustee in his total beneficial ownership of 346,155 shares. The filing states he "may be deemed to beneficially own" the trust-held shares.